Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NuvOx Pharma
AddedFeb 15, 2024
UpdatedJun 18, 2026
NuvOx Pharma

NuvOx Pharma

Series B

NuvOx Pharma, an Arizona-based pharmaceutical company, develops oxygen-delivering drugs for stroke, oncology, and sickle cell crisis.

HQ
Tucson, AZ, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

NuvOx Pharma, founded in Tucson, Arizona, is a pharmaceutical company dedicated to developing oxygen-delivering drugs aimed at reversing hypoxia. The company's core mission is to address the lack of oxygen in the body's cells, which is a critical factor in numerous fatal diseases. NuvOx's platform involves intravenous drugs that travel through the bloodstream to the lungs to pick up oxygen and deliver it to hypoxic tissues. Their primary focus areas include treatments for stroke, oncology, and sickle cell crisis, with several drugs in Phase II and Phase Ib trials.

Notable affiliated individuals and investors include experts in medical research and pharmaceutical development, although specific names are not provided. NuvOx Pharma has achieved significant milestones, such as advancing their drug candidates to Phase II and Phase Ib clinical trials. Their innovative approach to treating hypoxia has the potential to impact various medical fields significantly, offering new hope for patients suffering from conditions like stroke, cancer, and sickle cell disease.

NuvOx Pharma - Quick Facts

When was NuvOx Pharma founded?

NuvOx Pharma was founded in 2008.

Where is NuvOx Pharma's headquarters located?

NuvOx Pharma's headquarters is located in Tucson, AZ, US.

How much has NuvOx Pharma raised to-date?

As of Apr 26, 2023, NuvOx Pharma has raised a total of $19M (USD).

How many employees does NuvOx Pharma have?

NuvOx Pharma has 6 employees as of Feb 4, 2024.

NuvOx Pharma - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
  • 3250Manufacture of medical and dental instruments and supplies
  • 4649Wholesale of other household goods
Show 24 more industry codes
NAICS
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339112Surgical and Medical Instrument Manufacturing
  • 424000Merchant Wholesalers, Nondurable Goods
  • 424200Drugs and Druggists' Sundries Merchant Wholesalers
  • 424210Drugs and Druggists' Sundries Merchant Wholesalers
  • 456000Health and Personal Care Retailers
  • 330000Manufacturing
  • 420000Wholesale Trade
  • 450000Retail Trade
  • 620000Health Care and Social Assistance
  • 339000Miscellaneous Manufacturing
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3841Surgical And Medical Instruments And Apparatus
  • 5100Wholesale trade--nondurable goods
  • 5120Drugs, Drug Proprietaries, And Druggists' Sundries
  • 5122Drugs, Drug Proprietaries, and Druggists' Sundries
  • 5900Miscellaneous Retail
  • 8000Health Services
  • 5910Drug Stores And Proprietary Stores
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified